HLN — HALEON Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual income statement for HALEON, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	8,480	9,892	9,545	10,858	11,302
Cost of Revenue
Gross Profit	5,231	6,098	5,984	6,725	6,958
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	7,580	8,265	7,872	9,241	9,195
Operating Profit	900	1,627	1,673	1,617	2,107
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	886	1,591	1,636	1,618	1,628
Provision for Income Taxes
Net Income After Taxes	687	1,181	1,439	1,119	1,111
Minority Interest
Net Income Before Extraordinary Items
Net Income	655	1,145	1,390	1,060	1,049
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	655	1,145	1,390	1,060	1,049
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.13	0.174	0.198	0.176	0.143
Dividends per Share